CompletedNot Applicable

The Treatment of Shoulder-hand Syndrome in Hemiplegia Patients

China84 participantsStarted 2023-11-01

Plain-language summary

The purpose of this clinical study is to investigate effects of Kinesio taping (KT) combined with dry needling (DN) on myofascial trigger points (MTrPs) in post-stroke hemiplegic shoulder-hand syndrome (SHS). Methods: A prospective, double-blind randomized controlled trial was conducted on 84 SHS patients, who were randomized into three groups: DN (Group A), KT (Group B), and DN+KT (Group C), all receiving standard rehabilitation. VAS, ADL, FMA-UE, PROM, and 8-figure dimensional difference were assessed pre- and post-28-day treatment. Statistical analysis was performed using SPSS 27.0, with paired t-test for intragroup comparisons and independent sample t-test for intergroup comparisons, and statistical significance was set at P\<0.05.

Who can participate

Age range40 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Within the recovery period from stroke with stable vital signs * Diagnosis of Stage I shoulder-hand syndrome (SHS) * SHS onset within 3 months prior to enrollment * Aged between 40 and 80 years * Willingness to participate in the trial and provision of signed informed consent Exclusion Criteria: * SHS caused by brain trauma or other non-stroke etiologies * History of shoulder or neck pain due to cervical spondylosis or scapulohumeral periarthritis * Diagnosis of malignant tumors * Presence of psychotic disorders or other severe systemic diseases * Coagulation disorders * Skin allergies or leukemia contraindicating acupuncture treatment * Known skin allergy to Kinesio tape * Concurrent participation in other traditional Chinese medicine or interventional therapies during the trial period * Joint pain or dyskinesia resulting from peripheral neuropathy

What they're measuring

Pain Intensity

Timeframe: Baseline, 14 days, and 28 days post-treatment.

Upper Limb Motor Function

Timeframe: Baseline, 14 days, and 28 days post-treatment.

Trial details

NCT IDNCT07245472

SponsorHandan Central Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-01